Tag: Liraglutide
Biocon reports 30% revenue increase and ₹660 crore net profit in...
Biocon's Q1FY25 performance sees 117% EBITDA growth and ₹660 crore net profit, powered by strategic partnerships and biosimilar success
Biocon’s European partner Zentiva receives approval from UK MHRA for Liraglutide
The company had earlier announced about the approval received from the MHRA for Liraglutide